Skip to main content

Data Requests to Use Johnson and Johnson Data

Requests listing last updated July 12, 2019

All Requests

The YODA Project posts proposals once data access has been granted or denied.

128 Results
YODA PROJECT Protocol Number2018-3121
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided6
Complete
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2017-2306
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided5
Complete
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2017-2031
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided3
YODA PROJECT Protocol Number2017-1746
Product(s) of Interest
TOPAMAX® (Topiramate), SIMPONI® (Golimumab), REMICADE® (Infliximab), INVOKANA® (Canagliflozin), STELARA® (Ustekinumab), RAZADYNE® (Galantamine), RISPERDAL® (Risperidone)
No. Trials Provided43
YODA PROJECT Protocol Number2017-1706
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided2
YODA PROJECT Protocol Number2017-1701
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone)
No. Trials Provided6
YODA PROJECT Protocol Number2017-1676
Product(s) of Interest
INVEGA® (Paliperidone), RISPERDAL® (Risperidone)
No. Trials Provided11
Complete
Principal InvestigatorHiroyuki Uchida
Keio University School of Medicine, Department of Neuropsychiatry
Reports & Publications
YODA PROJECT Protocol Number2016-1176
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
YODA PROJECT Protocol Number2016-1122
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2016-1103
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
YODA PROJECT Protocol Number2016-1057
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
YODA PROJECT Protocol Number2016-0912
Product(s) of Interest
THERMOCOOL® SMARTTOUCH™ Catheter (Ablation Catheter)
No. Trials Provided1
YODA PROJECT Protocol Number2016-0897
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided2
YODA PROJECT Protocol Number2016-0880
Product(s) of Interest
INVEGA® (Paliperidone), RISPERDAL® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided49
Complete
Principal InvestigatorStefan Leucht
Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Technische Universität München
YODA PROJECT Protocol Number2016-0734
Product(s) of Interest
SIRTURO® (Bedaquiline/TMC207)
No. Trials Provided2
YODA PROJECT Protocol Number2016-0716
Product(s) of Interest
INVEGA®
No. Trials Provided1
YODA PROJECT Protocol Number2015-0678
Product(s) of Interest
INVEGA®
No. Trials Provided1
Complete
Principal InvestigatorSharon-Lise Normand
Harvard Medical School
YODA PROJECT Protocol Number2015-0617
Product(s) of Interest
INVEGA®
No. Trials Provided1
Complete
Principal InvestigatorKarestan Koenen
Harvard School of Public Health
Reports & Publications
YODA PROJECT Protocol Number2015-0612
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab), SIMPONI® (Golimumab)
No. Trials Provided16
YODA PROJECT Protocol Number2015-0514
Product(s) of Interest
LEVAQUIN® (Levofloxacin)
No. Trials Provided1
YODA PROJECT Protocol Number2014-0401
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2014-0340
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided9
YODA PROJECT Protocol Number2014-0334
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided4
YODA PROJECT Protocol Number2014-0291
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided3
Complete
Principal InvestigatorMichael Ward
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Reports & Publications
YODA PROJECT Protocol Number2018-2801
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Incomplete
Principal InvestigatorXianming Tan
University North Carolina at Chapel hill
Reports & Publications
YODA PROJECT Protocol Number2017-2651
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
YODA PROJECT Protocol Number2016-1171
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2016-1058
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Incomplete
Principal InvestigatorDaniel Moreira
University of Illinois at Chicago
Reports & Publications
YODA PROJECT Protocol Number2016-1046
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2016-0995
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided1
YODA PROJECT Protocol Number2016-0884
Product(s) of Interest
DOXIL® (Doxorubicin hydrochloride)
No. Trials Provided2
Incomplete
Principal InvestigatorJose Miguel Fernandez
Universidad Pompeu Fabra
Reports & Publications
YODA PROJECT Protocol Number2016-0774
Product(s) of Interest
PROCRIT® (Epoetin alfa)
No. Trials Provided2
YODA PROJECT Protocol Number2016-0767
Product(s) of Interest
SIRTURO® (Bedaquiline/TMC207)
No. Trials Provided2
YODA PROJECT Protocol Number2016-0766
Product(s) of Interest
RISPERDAL® (Risperidone), INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA®
No. Trials Provided15
YODA PROJECT Protocol Number2016-0698
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided4
Incomplete
Principal InvestigatorAndreas Goebel
University of Liverpool
Reports & Publications
YODA PROJECT Protocol Number2015-0691
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided21
Incomplete
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2015-0676
Product(s) of Interest
RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided2
Incomplete
Principal InvestigatorRobin Emsley
Department of Psychiatry, Faculty of Medicine and Health Sciences, University of Stellenbosch
Reports & Publications
YODA PROJECT Protocol Number2015-0649
Product(s) of Interest
REMICADE® (Infliximab), TOPAMAX® (Topiramate), INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone), RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided20
Incomplete
Principal InvestigatorChunhua Weng
Columbia University
Reports & Publications
YODA PROJECT Protocol Number2015-0587
Product(s) of Interest
SIRTURO® (Bedaquiline/TMC207)
No. Trials Provided1
YODA PROJECT Protocol Number2015-0565
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Incomplete
Principal InvestigatorSrikala Sridhar
Princess Margaret Cancer Center
Reports & Publications
YODA PROJECT Protocol Number2015-0527
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided9
YODA PROJECT Protocol Number2015-0522
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Incomplete
Principal InvestigatorByron Vaughn
University of Minnesota
Reports & Publications
YODA PROJECT Protocol Number2015-0416
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided9
YODA PROJECT Protocol Number2014-0317
Product(s) of Interest
RISPERDAL CONSTA® (Risperidone)
No. Trials Provided2
Incomplete
Principal InvestigatorJohn Carlson
Michigan State University - School Psychology Doctoral Program
Reports & Publications
YODA PROJECT Protocol Number2020-4211
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided6
Approved Pending DUA Signature
Principal InvestigatorLinong Ji
Peking University People's Hospital
YODA PROJECT Protocol Number2020-4175
Product(s) of Interest
INVEGA® (Paliperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone)
No. Trials Provided7
Approved Pending DUA Signature
Principal InvestigatorGeorgios Schoretsanitis
Zucker Hillside Hospital
YODA PROJECT Protocol Number2020-4165
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided1
Approved Pending DUA Signature
Principal InvestigatorZaid Hattab
National University Of Ireland Galway
YODA PROJECT Protocol Number2019-4134
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Approved Pending DUA Signature
Principal InvestigatorJayne Tierney
MRC Clinical Trials Unit at UCL
YODA PROJECT Protocol Number2019-4093
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
Approved with DUA Signature
Principal InvestigatorBasem Mishriky
East Carolina Univereseity
YODA PROJECT Protocol Number2019-4092
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided11
Approved Pending DUA Signature
Principal InvestigatorTianxi Cai
Department of Biostatistics, Harvard T.H. Chan School of Public Health
YODA PROJECT Protocol Number2019-4078
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate)
No. Trials Provided3
YODA PROJECT Protocol Number2019-4077
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided9
YODA PROJECT Protocol Number2019-4075
Product(s) of Interest
UPTRAVI® (Selexipag), TRACLEER® (Bosentan), OPSUMIT® (Macitentan)
No. Trials Provided5
Approved Pending DUA Signature
Principal InvestigatorRaymond Benza
Allegheny Health Network
YODA PROJECT Protocol Number2019-4071
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided15
Approved Pending DUA Signature
Principal InvestigatorFrank Moriarty
Royal College of Surgeons in Ireland
YODA PROJECT Protocol Number2019-4067
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab), SIMPONI® (Golimumab)
No. Trials Provided45
Approved Pending DUA Signature
Principal InvestigatorFlorence Bourgeois
Harvard Medical School
YODA PROJECT Protocol Number2019-4066
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided1
Approved Pending DUA Signature
Principal InvestigatorPhilip Robinson
University of Queensland
YODA PROJECT Protocol Number2019-4035
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
YODA PROJECT Protocol Number2019-4015
Product(s) of Interest
PLIVENSIA (Sirukumab)
No. Trials Provided2
Approved Pending DUA Signature
Principal InvestigatorJohn Peipert
Northwestern University
YODA PROJECT Protocol Number2019-4013
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2019-3999
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided16
YODA PROJECT Protocol Number2019-3995
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided12
YODA PROJECT Protocol Number2019-3980
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2019-3978
Product(s) of Interest
INVEGA® (Paliperidone), RISPERDAL® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided39
YODA PROJECT Protocol Number2019-3958
Product(s) of Interest
RISPERDAL® (Risperidone), INVEGA® (Paliperidone), INVEGA SUSTENNA® (Paliperidone palmitate), CONCERTA® (Methylphenidate HCl), RISPERDAL CONSTA® (Risperidone), TOPAMAX® (Topiramate), INVEGA®
No. Trials Provided108
YODA PROJECT Protocol Number2019-3943
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2019-3941
Product(s) of Interest
INVEGA® (Paliperidone), RISPERDAL® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate)
No. Trials Provided23
Ongoing
Principal InvestigatorSøren Dinesen Østergaard
Aarhus University
YODA PROJECT Protocol Number2019-3938
Product(s) of Interest
CONCERTA® (Methylphenidate HCl), RISPERDAL® (Risperidone)
No. Trials Provided2
YODA PROJECT Protocol Number2019-3936
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), ZYTIGA® (Abiraterone acetate), RAZADYNE® (Galantamine), DARZALEX® (Daratumumab)
No. Trials Provided6
YODA PROJECT Protocol Number2019-3893
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided6
YODA PROJECT Protocol Number2019-3886
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2019-3865
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided6
Ongoing
Principal InvestigatorRobert Gniadecki
University of Alberta, Department of Medicine & Dentistry, Division of Dermatology
YODA PROJECT Protocol Number2019-3850
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided1
YODA PROJECT Protocol Number2019-3829
Product(s) of Interest
DOXIL® (Doxorubicin hydrochloride)
No. Trials Provided2
Approved with DUA Signature
Principal InvestigatorLee Van Horn
University of New Mexico
YODA PROJECT Protocol Number2019-3827
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL CONSTA® (Risperidone), INVEGA® (Paliperidone), RISPERDAL® (Risperidone), INVEGA®
No. Trials Provided67
Ongoing
Principal InvestigatorAndreas Heinz
Charité - Universitätsmedizin Berlin
YODA PROJECT Protocol Number2019-3821
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone), RISPERDAL® (Risperidone), INVEGA®
No. Trials Provided16
Ongoing
Principal InvestigatorRobert McCutcheon
King's College London
YODA PROJECT Protocol Number2018-3813
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2018-3765
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided16
Ongoing
Principal InvestigatorAhmad Abuhelwa
University of South Australia
YODA PROJECT Protocol Number2018-3745
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Ongoing
Principal InvestigatorDavid Lorente
Medical Oncology Service, Hospital Provincial de Castellón
YODA PROJECT Protocol Number2018-3743
Product(s) of Interest
STELARA® (Ustekinumab), REMICADE® (Infliximab)
No. Trials Provided6
YODA PROJECT Protocol Number2018-3737
Product(s) of Interest
SIMPONI® (Golimumab), STELARA® (Ustekinumab), REMICADE® (Infliximab)
No. Trials Provided23
Ongoing
Principal InvestigatorShailja Shah
Vanderbilt University Medical Center
YODA PROJECT Protocol Number2018-3704
Product(s) of Interest
SIMPONI® (Golimumab), PLIVENSIA (Sirukumab)
No. Trials Provided2
YODA PROJECT Protocol Number2018-3476
Product(s) of Interest
STELARA® (Ustekinumab), REMICADE® (Infliximab)
No. Trials Provided10
Ongoing
Principal InvestigatorVivek Rudrapatna
University of California, San Francisco
YODA PROJECT Protocol Number2018-3321
Product(s) of Interest
DARZALEX® (Daratumumab)
No. Trials Provided5
YODA PROJECT Protocol Number2018-3236
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2018-3156
Product(s) of Interest
SIRTURO® (Bedaquiline/TMC207)
No. Trials Provided2
YODA PROJECT Protocol Number2018-3131
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab)
No. Trials Provided7
Ongoing
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
YODA PROJECT Protocol Number2018-3126
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab)
No. Trials Provided7
Ongoing
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
YODA PROJECT Protocol Number2018-3061
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided3
YODA PROJECT Protocol Number2018-3051
Product(s) of Interest
RISPERDAL® (Risperidone)
No. Trials Provided1
YODA PROJECT Protocol Number2018-3011
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Ongoing
Principal InvestigatorDavid Lorente
Medical Oncology Service, Hospital Provincial de Castellón
YODA PROJECT Protocol Number2018-2931
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided11
YODA PROJECT Protocol Number2018-2761
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2018-2686
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2017-2511
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided1
Ongoing
Principal InvestigatorRaphaël Porcher
Université Paris Descartes
YODA PROJECT Protocol Number2017-2486
Product(s) of Interest
PROCRIT® (Epoetin alfa)
No. Trials Provided5
YODA PROJECT Protocol Number2017-2381
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided4
YODA PROJECT Protocol Number2017-2326
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided1
Ongoing
Principal InvestigatorLiana Fraenkel
Yale University School of Medicine
YODA PROJECT Protocol Number2017-2036
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Ongoing
Principal InvestigatorAntonio Fojo
Columbia University Medical Center/ James J. Peters VA Medical Center
YODA PROJECT Protocol Number2017-1966
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided19
YODA PROJECT Protocol Number2017-1856
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab), SIMPONI® (Golimumab)
No. Trials Provided17
Ongoing
Principal InvestigatorAshwin Ananthakrishnan
Massachusetts General Hospital
YODA PROJECT Protocol Number2017-1846
Product(s) of Interest
INVEGA® (Paliperidone), RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA®
No. Trials Provided61
Ongoing
Principal InvestigatorAndreas Heinz
Department of Psychiatry und Psychotherapy, Charité-Universitätsmedizin Berlin
YODA PROJECT Protocol Number2017-1816
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided6
YODA PROJECT Protocol Number2017-1671
Product(s) of Interest
RAZADYNE® (Galantamine), RAZADYNE® (Galantamine hydrobromide)
No. Trials Provided5
YODA PROJECT Protocol Number2017-1521
Product(s) of Interest
RISPERDAL® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided9
YODA PROJECT Protocol Number2017-1466
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided3
YODA PROJECT Protocol Number2017-1456
Product(s) of Interest
SIMPONI® (Golimumab), STELARA® (Ustekinumab)
No. Trials Provided3
YODA PROJECT Protocol Number2017-1451
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided4
YODA PROJECT Protocol Number2017-1356
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
YODA PROJECT Protocol Number2017-1276
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2016-1196
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2016-1136
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
YODA PROJECT Protocol Number2016-1107
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided7
Incomplete
Principal InvestigatorFrank Scott
University of Colorado Anschutz Medical Campus
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2016-1038
Product(s) of Interest
TOPAMAX® (Topiramate)
No. Trials Provided2
YODA PROJECT Protocol Number2016-1005
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone), INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided38
YODA PROJECT Protocol Number2016-0979
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2016-0969
Product(s) of Interest
RISPERDAL® (Risperidone)
No. Trials Provided4
Incomplete
Principal InvestigatorSuzanne Reeves
University College London
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2016-0960
Product(s) of Interest
PROCRIT® (Epoetin alfa)
No. Trials Provided8
Ongoing
Principal InvestigatorGary Rosner
Johns Hopkins University
YODA PROJECT Protocol Number2016-0919
Product(s) of Interest
STELARA® (Ustekinumab), REMICADE® (Infliximab)
No. Trials Provided12
YODA PROJECT Protocol Number2016-0903
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided4
YODA PROJECT Protocol Number2016-0765
Product(s) of Interest
RAZADYNE® (Galantamine)
No. Trials Provided12
YODA PROJECT Protocol Number2016-0738
Product(s) of Interest
OLYSIO® (Simeprevir)
No. Trials Provided1
Incomplete
Principal InvestigatorChristophe Moreno
CUB Hôpital Erasme
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2016-0725
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone)
No. Trials Provided12
YODA PROJECT Protocol Number2015-0677
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided8
Ongoing
Principal Investigatorshomron Ben-Horin
Sheba Medical Center & Sun YatSen 1st affiliated hospital
YODA PROJECT Protocol Number2015-0644
Product(s) of Interest
RISPERDAL® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone), TOPAMAX® (Topiramate)
No. Trials Provided31
YODA PROJECT Protocol Number2015-0560
Product(s) of Interest
SIMPONI® (Golimumab), STELARA® (Ustekinumab)
No. Trials Provided3
YODA PROJECT Protocol Number2015-0500
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Incomplete
Principal InvestigatorUrban Emmenegger
Sunnybrook Odette Cancer Centre
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2014-0364
Product(s) of Interest
INVEGA® (Paliperidone), TOPAMAX® (Topiramate), RISPERDAL® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate)
No. Trials Provided20
Ongoing
Principal InvestigatorStefan Leucht
Klinik für Psychiatrie und Psychotherapie der TU-München Klinikum rechts der Isar
YODA PROJECT Protocol Number2014-0333
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Incomplete
Principal InvestigatorGuru Sonpavde
University of Alabama, Birmingham (UAB) School of Medicine
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.